DiseaseID 26038

高脯氨酸血症II型

Hyperprolinemia, Type Ii

SNOMEDCT_US_2016_09_01:An autosomal recessive proline metabolism disorder due to pyroline-5-carboxylate dehydrogenase deficiency. The condition is often benign but clinical signs may include seizures, intellectual defici

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Disease: 1Formula: 5Symptom: 4Target: 16Links: 33
Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id
26038
Core Entity Id
118606
Source Entity Count
1
Preferred Name
Hyperprolinemia, Type Ii
Name Cn
高脯氨酸血症II型
Name Pinyin
Gao Pu An Suan Xue Zheng Ii Xing
Name En
Hyperprolinemia, Type Ii
Name Latin
Bilingual Status
complete
Disease Type
Umls Disease Type
Disgenet Type
Mesh Class
Do Class
Hpo Class
Mesh Class Name
Hpo Class Name
Do Class Name
Disease Definition
SNOMEDCT_US_2016_09_01:An autosomal recessive proline metabolism disorder due to pyroline-5-carboxylate dehydrogenase deficiency. The condition is often benign but clinical signs may include seizures, intellectual deficit and mild developmental delay.
Version
v1,v2
Suppressed
No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name
Hyperprolinemia, Type Ii
Role
preferred

Cross References

Trusted external identifiers retained for this final record.

Umls
C2931835
Sym Map
SMDE01669
Etcm Disease
Hyperprolinemia, Type Ii
Itcmdb Generated
ITX-DISEASE-D04CDD66A31C

Attributes

Merged source attributes and domain-specific metadata.

Version
v1,v2
Suppress
0
Page Title
Disease Hyperprolinemia, Type Ii Details page
Basic Information
Disease Name
Hyperprolinemia, Type Ii
Global Category
Genetic diseases;Metabolic diseases;Rare diseases
Anatomical Category
Blood diseases;Mental diseases;Nephrological diseases;Neuronal diseases
Disease Definition
SNOMEDCT_US_2016_09_01:An autosomal recessive proline metabolism disorder due to pyroline-5-carboxylate dehydrogenase deficiency. The condition is often benign but clinical signs may include seizures, intellectual deficit and mild developmental delay.